Skip to main content
. 2024 Dec 4;11:1489671. doi: 10.3389/fmed.2024.1489671

Figure 4.

Figure 4

Evolution of liver function and blood routine test in response to pegylated interferon-α-2b over 48 weeks in all enrolled patients with hepatitis B virus-related compensated liver cirrhosis. Changes of (A) alanine aminotransferase (ALT) level, (B) aspartate aminotransferase (AST) level, (C) albumin level, (D) white blood cells (WBC) count, (E) neutrophils count, (F) platelets count, (G) hemoglobin (HGB) level at different observational time points. The points indicate median or mean, while the bars indicate interquartile range or standard deviation. Statistical analyses were performed using Kriskal-Wallis H test followed by Dunn’s multiple comparison test or one-way analysis of variance followed by Tukey test. #p < 0.05, ##p < 0.01, ###p < 0.001 compared with baseline.